New study tests inhaled steroid safety in fragile preemies
Symptom relief
Recruiting now
This early-stage study tests the safety of an inhaled steroid (ciclesonide) in 30 premature babies who are on breathing machines and at risk for a chronic lung condition called bronchopulmonary dysplasia. Researchers will monitor side effects like high blood sugar, growth changes…
Phase: PHASE1 • Sponsor: Venkatesh Sampath • Aim: Symptom relief
Last updated May 11, 2026 20:48 UTC